Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:315-321
Published online before print November 29, 2007, doi: 10.1161/ATVBAHA.107.149815
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/2/315    most recent
ATVBAHA.107.149815v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, Y.
Right arrow Articles by Wang, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, Y.
Right arrow Articles by Wang, N.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:315.)
© 2008 American Heart Association, Inc.


Cell Biology/Signaling

Suppression of Pro-inflammatory Adhesion Molecules by PPAR-{delta} in Human Vascular Endothelial Cells

Yanbo Fan; Ying Wang; Zhihui Tang; Hong Zhang; Xiaomei Qin; Yi Zhu; Youfei Guan; Xian Wang; Bart Staels; Shu Chien; Nanping Wang

From the Institute of Cardiovascular Science and Key Laboratory of Molecular Cardiovascular Science (Y.F., Y.W., Z.T., H.Z., X.Q., Y.Z., Y.G., X.W., N.W.), Peking University, Beijing, China; the Diabetes Center (Y.F., Y.W., Z.T., H.Z., X.Q., Y.Z. Y.G., X.W., N.W.), Peking University, Beijing, China; Institut Pasteur de Lille (B.S.) INSERM U545; Université de Lille 2, Faculté de Pharmacie et Faculté de Médecine, Lille, France; and the Departments of Bioengineering and Medicine (S.C.), University of California San Diego, La Jolla, Calif.

Correspondence to Nanping Wang, Institute of Cardiovascular Science, Peking University Health Science Center, Beijing 100083, China. E-mail npwang{at}bjmu.edu.cn

Abstract

Objective— Endothelial activation is implicated in atherogenesis and diabetes. The role of peroxisome proliferator-activated receptor-{delta} (PPAR-{delta}) in endothelial activation remains poorly understood. In this study, we investigated the anti-inflammatory effect of PPAR-{delta} and the mechanism involved.

Methods and Results— In human umbilical vein endothelial cells (HUVECs), the synthetic PPAR-{delta} ligands GW0742 and GW501516 significantly inhibited tumor necrosis factor (TNF)-{alpha}–induced expression of vascular cell adhesion molecule-1 and E-selectin (assayed by real-time RT-PCR and Northern blotting), as well as the ensuing endothelial-leukocyte adhesion. Activation of PPAR-{delta} upregulated the expression of antioxidant genes superoxide dismutase 1, catalase, and thioredoxin and decreased reactive oxygen species production in ECs. Chromatin immunoprecipitation assays showed that GW0742 switched the association of BCL-6, a transcription repressor, from PPAR-{delta} to the vascular cell adhesion molecule (VCAM)-1 promoter. Small interfering RNA reduced endogenous PPAR-{delta} expression but potentiated the suppressive effect of GW0742 on EC activation, which suggests that the nonliganded PPAR-{delta} may have an opposite effect.

Conclusions— We have demonstrated that ligand activation of PPAR-{delta} in ECs has a potent antiinflammatory effect, probably via a binary mechanism involving the induction of antioxidative genes and the release of nuclear corepressors. PPAR-{delta} agonists may have a potential for treating inflammatory diseases such as atherosclerosis and diabetes.

By using the selective agonists and siRNA-mediated gene silencing, we have demonstrated that ligand-activation of PPAR-{delta} in primary-cultured human endothelial cells has a potent antiinflammatory effect via a novel binary mechanism involving the induction of antioxidative genes and the release of nuclear corepressors.


Key Words: adhesion molecules • nuclear receptor • endothelium • gene expression • reactive oxygen species




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
L. Piqueras, M. J. Sanz, M. Perretti, E. Morcillo, L. Norling, J. A. Mitchell, Y. Li, and D. Bishop-Bailey
Activation of PPAR{beta}/{delta} inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release
J. Leukoc. Biol., July 1, 2009; 86(1): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Zhang, Y. Wang, Y. Fan, Z. Tang, and N. Wang
Overexpression of Adiponectin Receptors Potentiates the Antiinflammatory Action of Subeffective Dose of Globular Adiponectin in Vascular Endothelial Cells
Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 67 - 74.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. Shan, P. S. Palkar, I. A. Murray, E. I. McDevitt, M. J. Kennett, B. H. Kang, H. C. Isom, G. H. Perdew, F. J. Gonzalez, and J. M. Peters
Ligand Activation of Peroxisome Proliferator-Activated Receptor {beta}/{delta} (PPAR{beta}/{delta}) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression
Toxicol. Sci., October 1, 2008; 105(2): 418 - 428.
[Abstract] [Full Text] [PDF]